By starting at lower doses and increasing more gradually, microdosing prioritizes tolerance, consistency, and long-term success over rushing to higher doses
A plateau is not just a brief stall, but a prolonged period of stagnation or even rebound weight gain
After reaching goal weight and stabilizing for two to three months, most clinicians recommend reducing dose by 25 to 50 percent while monitoring weight stability
The GUIDE Model is unique in that it incentivizes health care providers to incorporate both the person with dementia and the caregiver (or caregivers) into the collaborative, multidisciplinary service approach
That difference can matter once treatment begins, especially when building habits, managing side effects, or maintaining results over time